← Open Payments lookup

PAUL WILKEN: Open Payments

NPI 1427579374 · ELKHORN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$285 in 14 payments from 7 companies in 2025. Trend: 2023 $362 · 2024 $153 · 2025 $285

Food & beverage: $285
CompanyPaymentsAmount
ABBVIE INC.5$97
Vanda Pharmaceuticals Inc.3$66
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$37
Axsome Therapeutics, Inc.1$25
Alkermes, Inc.1$24
E.R. Squibb & Sons, L.L.C.1$20
Supernus Pharmaceuticals, Inc.1$17

Products named: VRAYLAR, HETLIOZ, CAPLYTA, FANAPT, Auvelity, ARISTADA, COBENFY, Qelbree.

Industry payments across NE — which companies pay providers there.